|
|
Blood, 15 October 2007, Vol. 110, No. 8, pp. 2788.
 Previous Article | Table of Contents | Next Article 
TRANSPLANTATION
Comment on Chung et al, page 2803
IL-7: griffinesque role in GVHD
Pavan Reddy
UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER
The development of graft-versus-host disease (GVHD) and immunoincompetence are the major obstacles to successful utilization of allogeneic hematopoietic stem cell transplanation (allo-HSCT). In this issue, Chung and colleagues report that blockade of IL-7R impairs the bad— GVHD, and restores the good—immune reconstitution after allo-HSCT.
IL-7 is critical for the development and maintenance of T cells in humans and for both T and B cells in mice.1 Interleukin-7 receptor (IL-7R) consists of 2 chains, the IL-7R and the common cytokine receptor  -chain. The -chain is expressed by most hematopoietic cells, whereas IL-7R is expressed exclusively by lymphoid cells.1 Previous studies with infusion of exogenous IL-7 have shown variable effects on GVHD and immune reconstitution.2–5 Now, Chung and colleagues report on the effect of IL-7R blockade on GVHD and immune reconstitution after allo-HSCT. They show that inhibition of endogenous IL-7 with anti–IL-7 antibody treatment for 28 days reduced mortality, morbidity, and target-organ damage from GVHD in a lethally irradiated, major histocompatibility complex (MHC)–mismatched murine model. The authors report similar effects with IL-7–deficient recipients (but data are not shown in the manuscript). Notably, despite reduction in the expansion of mature donor T cells early after transplantation, the authors demonstrate preservation of thymic architecture, increased thymic T-cell reconstitution, and enhanced T-cell–dependent antibody responses late after HSCT. How can blockade of IL-7, a critical factor for thymic lymphopoiesis and peripheral T-cell homeostasis, result in better thymic reconstitution? Because the thymus itself is a GVHD target, and based on experiments with congenic mice, the authors posit that the magnitude of GVHD suppression by anti–IL-7 antibody treatment might eclipse any direct potential inhibitory effect on thymopoiesis.
These observations, while in accordance with some earlier observations,5 appear to contradict reports that showed improved immunoreconstitution without worsening GVHD in mice when treated with IL-7.2,3 The different outcomes are likely due to the consequence of potentially distinct effects from the blockade of endogenous IL-7 versus exogenously administered IL-7 in the context of irradiation-induced inflammation and lymphopenia.4 Additionally, the different model systems, T-cell sources, and doses, timing, and duration of cytokine modulation might also explain the divergent results. It is, however, important to note that the expression of IL-7R on mature T-cell subsets is variable and influenced by a variety of stimuli, and that it is also expressed on regulatory T cells, NKT cells, and  T cells, which modulate GVHD.1
While clinical trials with IL-7 are underway, this study raises important issues. It adds to the growing specter that IL-7 might enhance GVHD and retard immunoreconstitution. It reminds us that insights from animal models, especially when they conflict, must be extrapolated to humans with caution. Along with previous observations, this study further underscores the potent effects of IL-7 on immune modulation and reconstitution after allo-HSCT.2–5 Thus, much like taming the mythical griffin to harness its powerful effects, which could be harmful or beneficial, the potent effects of IL-7 after allo-HSCT need to be understood better before harnessing its clinical utility.
Footnotes
Conflict-of-interest disclosure: The author declares no competing financial interests. 
REFERENCES
- Mazzucchelli R and Durum SK. Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 2007; 7:144–154.[CrossRef][Medline]
[Order article via Infotrieve]
- Alpdogan O, Schmaltz C, Muriglan SJ, et al. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 2001; 98:2256–2265.[Abstract/Free Full Text]
- Alpdogan O, Muriglan SJ, Eng JM, et al. IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J Clin Invest 2003; 112:1095–1107.[CrossRef][Medline]
[Order article via Infotrieve]
- Gendelman M, Hecht T, Logan B, Vodanovic-Jankovic S, Komorowski R, Drobyski WR. Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease. J Immunol 2004; 172:3328–3336.[Abstract/Free Full Text]
- Sinha ML, Fry TJ, Fowler DH, Miller G, Mackall CL. Interleukin 7 worsens graft-versus-host disease. Blood 2002; 100:2642–2649.[Abstract/Free Full Text]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Prevention of graft-versus-host disease by anti–IL-7R antibody
- Brile Chung, Eric P. Dudl, Dullei Min, Lora Barsky, Nancy Smiley, and Kenneth I. Weinberg
Blood 2007 110: 2803-2810.
[Abstract]
[Full Text]
[PDF]
|
|
